Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

8.49
Data as of 3:12pm ET
 +0.03 / +0.35%
Today’s Change
3.05
Today|||52-Week Range
9.62
+152.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$78.3M

Company Description

Imprimis Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the commercial development of novel drug formulations and proprietary drug delivery vehicles. It focuses on meeting unmet patient needs through the development and commercialization of innovative proprietary sterile and topical drug formulations and technologies that are customized for patients. Its network of innovators includes inventive physicians and pharmacists. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.

Contact Information

Imprimis Pharmaceuticals, Inc.
12626 High Bluff Drive
San Diego California 92130
P:(858) 704-4040
Investor Relations:
(858) 704-4587

Employees

Shareholders

Other institutional8.71%
Individual stakeholders27.31%
Mutual fund holders1.25%

Top Executives

Mark L. BaumChief Executive Office & Director
Gary W. SeelhorstVice President-Corporate Development
Andrew R. BollVice President-Accounting & Public Reporting
Jen Turbiak CarrollHead-Media Relations
Jeannette V. FilipponeSecretary, Chief Legal Officer & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.